After Clinical Trial, Baricitinib Approved for Emergency Use

Baricitinib, a drug tested as part of the ACTT trials at Stanford, has been approved by the FDA for emergency use in treating COVID-19 patients.

COVID doctor: Herd immunity rests on naive and faulty logic. In practice, people will die.

Thomas Lew, MD discusses talks herd immunity and why it won't work

How DART Helps Physicians De-escalate Situations

DART (Distress Activation Response Team) is a team de-escalation program that also sets a behavioral agreement with the patient or their family member.

Getting COVID-19 didn't help Trump evolve his thinking

Dr. Thomas Lew, MD discusses Trump's public health messaging on a recent USA Today article

Mr. President, people with COVID-19 are somebody to me, not 'nobody'

Dr. Thomas Lew, MD talks to USA Today about the importance of masks and social distancing

Opinion: Don’t believe nonsense that COVID-19 deaths are vastly overstated

Gross misinterpretation of CDC data hurts efforts to fight the virus.

Integrating AI

Ron Li and his team are leveraging AI and machine learning to solve some of the most complex issues that plague health care systems.

Virtual anatomy labs and at-home dissections: Stanford summer programs thrived online

Clinical Summer Internship Co-Director, Sarita Khemani found creative ways to teach summer courses to high school and undergraduate students during the pandemic.